Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (61-70 of 1,857) with videos related to

Pageof 186
Sort By:
Clinical Cardiology|June 1, 1990
The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertensionW H Frishman
Cardiology in Review|March 15, 2022
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus 2, Part 7: COVID-19, What Next?William H Frishman
The American Journal of Medicine|July 18, 2015
Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies?William H Frishman
The New England Journal of Medicine|June 17, 1982
Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonistsW H Frishman
Heart Disease (Hagerstown, Md.)|November 21, 2002
An odyssey of a clinical researcherWilliam H Frishman
Journal of Clinical Pharmacology|July 1, 1993
A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertensionW H Frishman
Progress in Cardiovascular Diseases|December 17, 2016
Beta-Adrenergic Receptor Blockers in Hypertension: Alive and WellWilliam H Frishman
Cardiology in Review|December 7, 2016
Cardiology in Review: the First 25 YearsWilliam H Frishman
Cardiology in Review|December 7, 2016
Welcome, Peter Zimetbaum, MDWilliam H Frishman
Journal of the American College of Cardiology|February 21, 2004
Cyclooxygenase inhibition in patients with coronary artery diseaseWilliam H Frishman
Pageof 186

Showing results (61-70 of 1,857) with videos related to

Sort By:
Pageof 186
Clinical Cardiology|June 1, 1990
The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertensionW H Frishman
Cardiology in Review|March 15, 2022
The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus 2, Part 7: COVID-19, What Next?William H Frishman
The American Journal of Medicine|July 18, 2015
Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies?William H Frishman
The New England Journal of Medicine|June 17, 1982
Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonistsW H Frishman
Heart Disease (Hagerstown, Md.)|November 21, 2002
An odyssey of a clinical researcherWilliam H Frishman
Journal of Clinical Pharmacology|July 1, 1993
A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertensionW H Frishman
Progress in Cardiovascular Diseases|December 17, 2016
Beta-Adrenergic Receptor Blockers in Hypertension: Alive and WellWilliam H Frishman
Cardiology in Review|December 7, 2016
Cardiology in Review: the First 25 YearsWilliam H Frishman
Cardiology in Review|December 7, 2016
Welcome, Peter Zimetbaum, MDWilliam H Frishman
Journal of the American College of Cardiology|February 21, 2004
Cyclooxygenase inhibition in patients with coronary artery diseaseWilliam H Frishman
Pageof 186